Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medico RemediesNSE:MEDICO -8.12%88 3-1 Month Momentum % is 2.67% as of Sep. 02, 2026. GuruFocus rates NSE:MEDICO with a GF Score™ of 88/100 and a GF Value™ of ₹77.99 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 1,024 Drug Manufacturers companies, Medico Remedies ranks better than 64.84% on this metric.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-09-02), Medico Remedies's 3-1 Month Momentum % is 2.67%.
The industry rank for Medico Remedies's 3-1 Month Momentum % or its related term are showing as below:
NSE:MEDICO's 3-1 Month Momentum % is ranked better than 64.84% of 1024
companies
in the Drug Manufacturers industry
Industry Median: -3.385
vs NSE:MEDICO: 2.67
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Medico Remedies 3-1 Month Momentum % Related Terms
NSE:MEDICO vs ZTS: 3-1 Month Momentum % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Medico Remedies's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medico Remedies 3-1 Month Momentum % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Medico Remedies's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Medico Remedies's 3-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medico Remedies (NSE:MEDICO) has a 3-1 Month Momentum % of 2.67% as of Sep. 02, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Medico Remedies and its competitors. According to the industry distribution chart, Medico Remedies ranks #360 out of 1024 companies in the Drug Manufacturers industry, placing it in the top 35.2%.
Is Medico Remedies' 3-1 Month Momentum % too high?
Medico Remedies' current 3-1 Month Momentum % is 2.67%. Based on the distribution chart, Medico Remedies ranks #360 out of 1024 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Medico Remedies has a GF Score™ of 88/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medico Remedies' 3-1 Month Momentum % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Medico Remedies ranks #360 out of 1024 companies for 3-1 Month Momentum %. This puts Medico Remedies in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Drug Manufacturers company?
A good 3-1 Month Momentum % depends on the Drug Manufacturers industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Medico Remedies and its competitors. Medico Remedies's current 3-1 Month Momentum % is 2.67%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medico Remedies stock overvalued right now?
Based on GuruFocus' analysis, Medico Remedies (NSE:MEDICO) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹77.99, compared to a current price of ₹38.91 — trading 50.1% below its estimated fair value. The current 3-1 Month Momentum % is 2.67%. Medico Remedies' overall GF Score™ is 88/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Medico Remedies (NSE:MEDICO), the current 3-1 Month Momentum % is 2.67% as of Sep. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medico Remedies (NSE:MEDICO) Overvalued in 2026?
Based on GuruFocus' analysis, Medico Remedies stock appears to be undervalued.
The current stock price of ₹38.91 is trading 50.1% below its estimated GF Value™ of ₹77.99.
GuruFocus considers Medico Remedies to be Significantly Undervalued.
Key valuation signals for NSE:MEDICO:
3-1 Month Momentum %: 2.67%
GF Value™: ₹77.99 vs. price of ₹38.91 (50.1% below fair value)
No single metric tells the full story. See the NSE:MEDICO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medico Remedies Ltd is a manufacturer, supplier, and exporter of pharmaceutical drugs. It operates in single segment single segment of manufacturing medicines including Antihy pertensive Antidiabetics Antibictics Diuretics, Antimalarials, NSAIDS Tablets, Antireterovirals, Anti-Ulcer Drugs and Antacids Tablets, so many drugs used for treatment of so many diseases for oral use as well as external preparations like creams & ointments which includes anti infectives ,antifungals ,antibiotics ,steroidal preparations etc. In addition, it also sells other drugs such as antihistaminic, antidiabetics, cardiovascular drugs, diuretics, anti-epileptics, combination drug kits, syrups and cream, and gel for various therapeutic segments.
88GF Score
Get the complete analysis for NSE:MEDICO
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:MEDICO has been successfully added to your 
